Overall rank by patents
#16,561
Across all tracked assignees
USPTO PatentsView assignee record - 17 granted patents across 14 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).
The verdict
Annikki holds 17 US patents across 14 technology areas, rank #16,561 of 50,000 tracked assignees.
Annikki Gmbh has been granted 17 US utility patents between 2015 and 2023, placing Annikki Gmbh at rank #16,561 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.1 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a Foreign Corporation, Annikki Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Annikki sits between Altek Biotechnology Corporation (17 patents, rank #16,557) and As0001, Inc. (17 patents, rank #16,565) - the closest US assignees by grant volume. The composite Innovation Score of 39.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 13 in the 2015–2019 window, a -69% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Annikki Gmbh's 18.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Annikki Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ALTEK BIOTECHNOLOGY CORPORATION
17 patents
AMBASSADOR ASSET MANAGEMENT LIMITED
17 patents
AMORPHICAL LTD
17 patents
AMRONA AG
17 patents
AO Technology AG
17 patents
APACHE CORPORATION
17 patents
ARMOR
17 patents
AS0001, Inc.
17 patents
ANNIKKI GMBH
17 patents
What this shows Annikki holds 17 patents at rank #16,561, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #16,561 in granted patent volume.
Other assignees with the most granted patents in Annikki's primary technology class.
Annikki's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 11.8% |
| 2016 | 2 | 11.8% |
| 2017 | 2 | 11.8% |
| 2018 | 4 | 23.5% |
| 2019 | 3 | 17.6% |
| 2020 | 1 | 5.9% |
| 2022 | 2 | 11.8% |
| 2023 | 1 | 5.9% |
Top 14 of 14 technology areas
Overall rank by patents
#16,561
Across all tracked assignees
39.1 out of 100
How to use this portfolio
Annikki's 17 grants land it in the top 39% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.